Introduction {#section5-1753944718792420}
============

Outcome after out-of-hospital cardiac arrest (OHCA) has markedly improved in the past years.^[@bibr1-1753944718792420][@bibr2-1753944718792420]--[@bibr3-1753944718792420]^ While the overall mortality rate is still considerable, the patients who do survive tend to have a good neurological outcome.^[@bibr4-1753944718792420][@bibr5-1753944718792420]--[@bibr6-1753944718792420]^ Many studies have focused on short-term outcome after OHCA,^[@bibr7-1753944718792420][@bibr8-1753944718792420][@bibr9-1753944718792420][@bibr10-1753944718792420]--[@bibr11-1753944718792420]^ and studies on the elderly have increased during the past years.^[@bibr12-1753944718792420][@bibr13-1753944718792420][@bibr14-1753944718792420][@bibr15-1753944718792420][@bibr16-1753944718792420][@bibr17-1753944718792420]--[@bibr18-1753944718792420]^ Since older studies reported dismal outcomes in elderly patients after cardiopulmonary resuscitation (CPR),^[@bibr19-1753944718792420]^ there still may be reluctance to institute maximal treatment in all patients for fear of only generating a greater number of survivors with poor functional outcomes.^[@bibr20-1753944718792420],[@bibr21-1753944718792420]^

Several recent studies show that with increasing age, short-term survival decreases but survivors display a good neurologic outcome.^[@bibr13-1753944718792420][@bibr14-1753944718792420]--[@bibr15-1753944718792420]^ Long-term survival after OHCA seems to approach the general population,^[@bibr22-1753944718792420][@bibr23-1753944718792420][@bibr24-1753944718792420]--[@bibr25-1753944718792420]^ but little is known on the long-term survival of elderly patients who survive until hospital discharge.^[@bibr16-1753944718792420][@bibr17-1753944718792420]--[@bibr18-1753944718792420]^ To what extent elderly OHCA patients benefit from early treatment as compared with younger patients and the general population was investigated in the current study.

Materials and methods {#section6-1753944718792420}
=====================

Study design and setting {#section7-1753944718792420}
------------------------

The University Medical Center Groningen (UMCG) is the main tertiary referral hospital for the north-eastern part of the Netherlands, which provides 24/7 emergency care in a region with 750,000 inhabitants.^[@bibr26-1753944718792420]^ It operates in combination with multiple emergency medical services (EMS) in this area. A driver with a paramedical background and a nurse staff each ambulance, and both are trained and qualified to perform Advanced Cardiac Life Support (ACLS) according to the European Resuscitation Council guidelines, such as advanced airway interventions, administration of inotropic drugs and use of a defibrillator.^[@bibr27-1753944718792420]^ In case of resuscitation, a backup ambulance is always sent. The nurse staff always commences CPR but has the discretion to discontinue if the patient has a 'do not attempt CPR' decision or a nonshockable rhythm present for more than 20 minutes. Except for these patients, all other OHCAs including EMS-witnessed arrests are transported to our center where resuscitation is continued or postresuscitation care is given following ACLS guidelines.^[@bibr27-1753944718792420]^ When patients present with an ST-segment elevation myocardial infarction (STEMI) after OHCA we perform percutaneous coronary intervention (PCI) in patients with return of spontaneous circulation (ROSC), including elderly patients.^[@bibr28-1753944718792420]^ Patients requiring continuous mechanical ventilation were transferred to the intensive care unit (ICU) for postresuscitation care. Treatment was left at the discretion of the attending physicians. If brainstem reflexes (i.e. absent pupillary light response and corneal reflexes) and motor scores were absent, no further life-sustaining treatment was delivered. In all other cases, additional somatosensory-evoked-potential (SSEP) monitoring was done and in the case of absent bilateral negative 20 (N20) SSEPs, active treatment was also withdrawn. Electroencephalography (EEG) analysis was performed when seizures or myoclonus was present. Seizures were treated with antiepileptic drugs; in the case of *myoclonus status epilepticus*, treatment was also stopped.^[@bibr29-1753944718792420],[@bibr30-1753944718792420]^ In these patients, active therapies were discontinued, and treatment was altered to comfort care. The institutional review board \[Medisch Ethische Toetsingscommissie (METc) of the UMCG\] approved the study and waived the need for informed consent due to the observational nature of the study (METc 2011.374).

Patients {#section8-1753944718792420}
--------

We studied all adult (⩾ 18 years) patients who were transferred to our hospital after OHCA during the years 2001--2010. Data were collected retrospectively from the medical records of the Ambulance System. During the study period, mild therapeutic hypothermia (MTH) was initiated if patients had a Glasgow Coma Score \< 8. These patients were cooled to 32--34°C for 24 h and thereafter, passively rewarmed to 36°C. In this cohort, we defined patients with an age of ⩾ 75 years as elderly and used the younger patients for comparison of outcomes in both categories.

Data on prehospital characteristics, medical history, electrocardiography (ECG), SSEP, EEG and laboratory values were gathered from the hospital information system. Neurological status was classified using the cerebral performance category (CPC) from the clinical patient notes made during outpatient follow-up assessments by cardiologists, rehabilitation specialists or, when indicated, neurologists. Survival status of patients discharged alive was obtained from the municipal personal records database on 20 December 2017, with a maximum follow up of 16.4 years.

Statistical analysis {#section9-1753944718792420}
--------------------

Continuous data are presented as either means ± standard deviation for normally distributed variables or medians and interquartile ranges for skewed data, or as group percentages with 95% confidence intervals (CI) for categorical variables. We determined outcome in subgroups dependent on initial rhythm \[ventricular fibrillation (VF) *versus* no-VF\] and implemented treatment (PCI *versus* no PCI, MTH *versus* no MTH). We recorded age, sex and known factors associated with outcome: initial rhythm and in-hospital treatment (PCI and MTH) and left ventricular function.

Statistical analysis was performed using the chi-square test for categorical and the Mann--Whitney *U* test or Student's *t* test for skewed continuous and normally distributed variables, respectively. Kaplan--Meier survival analysis was used to assess long-term survival and the log-rank test was used to compare survival across subgroups. For each OHCA patient, the actual survival was compared with the predicted survival rates of the general population standardized for age, sex and calendar year. These predicted survival rates were obtained from the Dutch Census Bureau, which predicts general population survival annually.^[@bibr31-1753944718792420]^ We identified independent predictors of in-hospital mortality, coronary angiography (CAG), PCI and MTH using multivariable logistic regression analyses. Univariable analyses were conducted on all known predictors for mortality, which were added without any transformation. A *p* \< 0.25 was used for inclusion in the multivariable model. Calibration of the multivariable models was checked with Hosmer--Lemeshow tests and by plotting observed proportions against the predicted risks of 10 equally sized groups. We used complete-case analyses because all variables in our multivariable models had fewer than 5% missing values.^[@bibr32-1753944718792420]^ Statistical significance was defined as a two-sided *p* value of \< 0.05. Statistical analyses were performed with Stata version 15.1 (StataCorp, 2017, College Station, Texas: StataCorp LLC).

Results {#section10-1753944718792420}
=======

Prehospital characteristics of all admitted patients {#section11-1753944718792420}
----------------------------------------------------

From 2001 to 2010, a total of 810 patients were admitted after OHCA ([Figure 1](#fig1-1753944718792420){ref-type="fig"}). Of these, 188 (23%) patients were ⩾ 75 years with a mean age of 81 ± 5 years. Baseline and clinical characteristics of patients aged \< 75 years and ⩾ 75 years are presented in [Table 1](#table1-1753944718792420){ref-type="table"}. The location of arrest differed between both groups and elderly patients less frequently had an initial rhythm of VF. There was no difference between the two age groups in the fraction of patients who achieved ROSC, although upon arrival at the emergency department, younger patients more often had achieved ROSC. Elderly patients also had an increased incidence of prior cardiovascular disease and risk factors. More specifically, elderly patients were more frequently known with a previous myocardial infarction, cerebrovascular accident, hypertension, diabetes and concurrent malignancy.

![Flow diagram of study population.\
CPC, cerebral performance category; OHCA, out-of-hospital cardiac arrest; ROSC, return of spontaneous circulation.](10.1177_1753944718792420-fig1){#fig1-1753944718792420}

###### 

Prehospital characteristics and medical history of all patients.

![](10.1177_1753944718792420-table1)

  ----------------------------------------------------------------------------------------------------------------
                                                                Total\      \< 75 years\   ⩾ 75 years\   p value
                                                                n = 810     n = 622        n = 188       
  ------------------------------------------------------------- ----------- -------------- ------------- ---------
  Age^[\*](#table-fn1-1753944718792420){ref-type="table-fn"}^   63 ± 15     57 ± 12        81 ± 5        \<0.001

  Male sex (%)                                                  572 (71%)   448 (72%)      124 (66%)     0.110

  **Prehospital characteristics**                                                                        

  Location (%)                                                                                           \<0.001

   Home                                                         374 (46%)   280 (45%)      94 (50%)      

   Public place                                                 190 (24%)   164 (26%)      26 (14%)      

   Other                                                        116 (14%)   91 (15%)       25 (13%)      

   Ambulance                                                    60 (7%)     47 (8%)        13 (7%)       

   Unknown                                                      70 (9%)     40 (6%)        30 (16%)      

  Witnessed arrest (%)                                          642 (79%)   504 (81%)      138 (73%)     0.964

  Bystander CPR (%)                                             460 (57%)   366 (59%)      94 (50%)      0.160

  Initial rhythm (%)                                                                                     \<0.001

   VF                                                           518 (64%)   421 (68%)      97 (52%)      

   PEA                                                          149 (18%)   97 (16%)       52 (28%)      

   Asystole                                                     116 (14%)   84 (14%)       32 (17%)      

   Pulseless VT                                                 27 (3%)     20 (3%)        7 (4%)        

  ROSC before ED arrival (%)                                    473 (58%)   374 (60%)      99 (53%)      0.013

  ROSC (%)                                                      551 (68%)   426 (69%)      125 (67%)     0.606

  **Cardiovascular history and risk factors**                                                            

  History of CVD (%)                                            257 (32%)   169 (27%)      88 (48%)      \<0.001

  Myocardial infarction (%)                                     148 (18%)   98 (16%)       50 (27%)      \<0.001

  STEMI (%)                                                     131 (16%)   86 (14%)       45 (24%)      \<0.001

  PCI (%)                                                       61 (8%)     46 (7%)        15 (8%)       0.680

  CABG (%)                                                      57 (7%)     31 (5%)        26 (14%)      \<0.001

  Angina (%)                                                    79 (10%)    49 (8%)        30 (16%)      \<0.001

  Cerebrovascular accident (%)                                  51 (6%)     33 (5%)        18 (10%)      0.024

  History of VF (%)                                             16 (2%)     11 (2%)        5 (3%)        0.400

  Malignancy (%)                                                35 (4%)     16 (4%)        19 (10%)      \<0.001

  Hypertension (%)                                              196 (24%)   141 (23%)      55 (29%)      0.031

  Hypercholesterolemia (%)                                      78 (10%)    65 (11%)       13 (7%)       0.180

  Diabetes (%)                                                  108 (13%)   72 (12%)       36 (19%)      0.004

  **Medication history**                                                                                 

  Beta blocker (%)                                              185 (23%)   124 (20%)      61 (32%)      \<0.001

  ACE inhibitor (%)                                             125 (15%)   80 (13%)       45 (24%)      \<0.001

  AT-II receptor antagonist (%)                                 56 (7%)     39 (6%)        17 (9%)       0.043

  Diuretics (%)                                                 142 (18%)   87 (14%)       55 (29%)      \<0.001

  Antiplatelet therapy (%)                                      126 (16%)   83 (13%)       43 (23%)      \<0.001

  Coumarin derivatives (%)                                      110 (14%)   72 (12%)       38 (20%)      \<0.001

  Statins (%)                                                   150 (19%)   107 (17%)      43 (23%)      0.003

  Antiarrhythmics (%)                                           33 (4%)     18 (3%)        15 (8%)       \<0.001

  Oral antidiabetic therapy (%)                                 57 (7%)     37 (6%)        20 (11%)      0.003

  Insulin (%)                                                   35 (4%)     30 (5%)        5 (3%)        0.390
  ----------------------------------------------------------------------------------------------------------------

Mean ± standard deviation.

ACE, angiotensin-converting enzyme; AT, angiotensin; CABG, coronary artery bypass grafting; CPR, cardiopulmonary resuscitation; CVD, cardiovascular disease; ED, emergency department; PCI, percutaneous coronary intervention; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; STEMI, ST-segment elevation myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.

In-hospital characteristics of patients who achieved return of spontaneous circulation {#section12-1753944718792420}
--------------------------------------------------------------------------------------

[Table 2](#table2-1753944718792420){ref-type="table"} summarizes the clinical characteristics, angiography data and outcome of the patients who achieved ROSC. After ROSC, the initial Glasgow Coma Scores were equally low in the elderly and younger cohort, with median scores of 3 (3--5) and 3 (3--6), *p* = 0.358, respectively. Elderly patients underwent fewer primary CAGs, were less often diagnosed with a STEMI, had smaller creatine kinase-myocardial band (CK-MB) and troponin T levels and presented with higher N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels (*p* \< 0.001 for all). There were no differences in glucose, lactate, pH, and base excess between these groups. Among the elderly, CAG was associated with an initial rhythm of VF, an ST-segment elevation on the ECG and higher arterial pH levels at admission ([Supplementary Table 1](http://journals.sagepub.com/doi/suppl/10.1177/1753944718792420)).

###### 

Clinical characteristics, treatment and outcome after return of spontaneous circulation.

![](10.1177_1753944718792420-table2)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                            Total\               \< 75 years\         ⩾ 75 years\           *p* value
                                                                                            *n* = 551 (68%)      *n* = 426 (68%)      *n* = 125 (66%)       
  ----------------------------------------------------------------------------------------- -------------------- -------------------- --------------------- -----------
  **Clinical characteristics**                                                                                                                              

  Glasgow Coma Score at admission^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^   4 (3, 13)            4 (3, 14)            3 (3, 9)              0.450

  STEMI (%)                                                                                 183 (33%)            157 (39%)            26 (22%)              \<0.001

  NSTEMI (%)                                                                                72 (13%)             51 (12%)             21 (17%)              0.160

  Wall motion abnormalities (%)                                                             82 (15%)             73 (32%)             9 (21%)               0.150

  LVEF (%)                                                                                                                                                  0.830

   Poor--moderate                                                                           62 (24%)             50 (31%)             12 (33%)              

   Reasonable--normal                                                                       133 (65%)            109 (69%)            24 (67%)              

  **Laboratory values**                                                                                                                                     

  Glucose^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                           12.7 (9.9, 16.9)     12.3 (9.6, 16.6)     13.2 (10.6, 17.1)     0.060

  Lactate^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                           6.2 (2.95, 9.75)     6.3 (2.9, 9.9)       5.4 (3.1, 8.7)        0.470

  pH^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                                7.25 (7.10, 7.33)    7.25 (7.1, 7.32)     7.27 (7.11, 7.34)     0.510

  Base excess^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                       −8.1 (−14.5, −3.9)   −8.1 (−14.7, −3.8)   −7.9 (−12.9, −3.95)   0.640

  CK max^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                            1943 (436, 5585)     2390 (607, 6376)     628 (286, 3104)       \<0.001

  CK-MB max^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                         169 (64, 554)        214 (77, 587)        110 (44, 241)         \<0.001

  Troponin T max^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                    2.22 (0.29, 11.33)   2.53 (0.39, 12.30)   0.99 (0.20, 6.30)     0.016

  NT-pro BNP^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^                        313 (75, 1607)       229 (69, 898)        1731 (312, 3619)      \<0.001

  **Treatment**                                                                                                                                             

  Coronary angiography (%)                                                                  295 (54%)            255 (60%)            40 (32%)              \<0.001

   Primary                                                                                  217 (39%)            185 (43%)            32 (26%)              \<0.001

   Secondary                                                                                78 (14%)             70 (16%)             8 (6%)                0.005

  Door to balloon time (min)^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^        88 (56, 128)         88 (55, 125)         83 (61, 137)          0.270

  Culprit lesion known (%)                                                                  295 (54%)            255 (60%)            40 (32%)              0.089

   Right coronary artery                                                                    67 (12%)             58 (14%)             9 (7%)                

   Left anterior descending                                                                 111 (20%)            97 (23%)             14 (11%)              

   Circumflex                                                                               44 (8%)              37 (9%)              7 (6%)                

   Left main                                                                                12 (2%)              7 (2%)               5 (4%)                

   Graft                                                                                    4 (1%)               4 (1%)               0 (0%)                

   Unknown or multiple                                                                      32 (6%)              28 (7%)              4 (3%)                

   No culprit                                                                               25 (5%)              24 (6%)              1 (1%)                

  PCI (%)                                                                                   215 (39%)            184 (43%)            31 (25%)              \<0.001

   Primary                                                                                  191 (35%)            164 (39%)            27 (22%)              \<0.001

   Secondary                                                                                24 (4%)              20 (5%)              4 (2%)                0.470

  Intra-aortic balloon pump (%)                                                             73 (13%)             60 (14%)             13 (10%)              0.290

  Mild therapeutic hypothermia (%)                                                          201 (37%)            161 (38%)            40 (32%)              0.280

  Mechanical ventilation (%)                                                                145 (26%)            118 (28%)            27 (22%)              0.200

  **Outcome**                                                                                                                                               

  Length of hospital stay (days)^[\*](#table-fn3-1753944718792420){ref-type="table-fn"}^    6 (3, 18)            7 (3, 20)            4 (2,12.5)            \<0.001

  In-hospital death (%)                                                                     268 (49%)            184 (43%)            84 (67%)              \<0.001

   Neurological bad outcome                                                                 184 (33%)            132 (31%)            52 (42%)              

   Cardiogenic shock                                                                        43 (8%)              25 (6%)              18 (14%)              

   Multiorgan failure                                                                       17 (3%)              12 (3%)              5 (4%)                

   Other                                                                                    24 (4%)              15 (4%)              9 (7%)                

  Hospital survival (%)                                                                     283 (51%)            242 (57%)            41 (33%)              \<0.001

  CPC at discharge (%)                                                                                                                                      0.041

   1                                                                                        239 (84%)            209 (86%)            30 (71%)              

   2                                                                                        36 (13%)             27 (11%)             9 (21%)               

   3                                                                                        9 (3%)               6 (3%)               3 (7%)                

  Survival at end of follow up (%)                                                          185 (33%)            178 (42%)            7 (6%)                \<0.001
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Median (interquartile range).

CK-MB, creatine kinase-myocardial band; CPC, cerebral performance category; LVEF, left ventricular ejection fraction; (N)STEMI, (non)-ST-segment elevation myocardial infarction; NT-pro BNP, N-terminal prohormone of brain natriuretic peptide; PCI, percutaneous coronary intervention; ROSC, return of spontaneous circulation.

Treatment {#section13-1753944718792420}
---------

Only 31 patients (25%) from the elderly group underwent PCI *versus* 184 patients (43%) in the younger group (*p* \< 0.001). In both younger and elderly patients, independent predictors of PCI were the presence of ST-segment elevation on the ECG and higher serum CK-MB levels \[[Supplementary Table 2(a)](http://journals.sagepub.com/doi/suppl/10.1177/1753944718792420), [2(b)](http://journals.sagepub.com/doi/suppl/10.1177/1753944718792420)\]. MTH was similarly used in the elderly (32%, 95% CI 24--41%) and younger (38%, 95% CI 33--43%) patients (*p* = 0.277). In the elderly, an initial rhythm of VF and higher serum CK-MB levels were independently associated with institution of MTH ([Supplementary Table 3](http://journals.sagepub.com/doi/suppl/10.1177/1753944718792420)). There were no statistically significant differences in the use of an intra-aortic balloon pump and mechanical ventilation between both groups ([Table 2](#table2-1753944718792420){ref-type="table"}).

Outcome {#section14-1753944718792420}
-------

Survival to hospital discharge was lower in elderly patients with only 33% (95% CI 25--42%) surviving compared with 57% (95% CI 52--62%) in the younger group (*p* \< 0.001; [Table 2](#table2-1753944718792420){ref-type="table"}). Being elderly was independently associated with in-hospital mortality when adjusted for known prognostic factors \[i.e. sex, initial rhythm, bystander CPR, witnessed arrest, arterial glucose and pH levels, and prior CVD ([Supplementary Table 4](http://journals.sagepub.com/doi/suppl/10.1177/1753944718792420))\]. Of the 41 elderly patients who survived to hospital discharge, 24 (59%, 95% CI 42--74%) had VF *versus* 17 (41%, 95% CI 26--58%) patients with non-VF (*p* = 0.600). In younger patients, survival in the VF group was 207 (86%, 95% CI 81--90%) *versus* 35 (15%, 95% CI 10--20%) in the non-VF patients (*p* \< 0.001). Only Glasgow Coma Score at admission was independently associated with mortality in the elderly ([Supplementary Table 5](http://journals.sagepub.com/doi/suppl/10.1177/1753944718792420)). Length of hospital stay was shorter in the elderly patients ([Table 2](#table2-1753944718792420){ref-type="table"}), but length of hospital stay was similar for hospital survivors in both groups.

After hospital discharge, survival in elderly patients was worse in comparison with younger patients ([Figure 2](#fig2-1753944718792420){ref-type="fig"}). The 1-year survival in the overall OHCA group after hospital discharge was 94% (95% CI 91--97%) and 5-year survival was still 85% (95% CI 80--89%). In contrast, in the patients aged ⩾ 75 years, 1-year survival was only 76% (95% CI 60--88%) and 5-year survival dropped to 59% (95% CI 42--74%). However, when standardized for sex, age and calendar year, long-term survival approached that of the general population **(**[Figure 3](#fig3-1753944718792420){ref-type="fig"}). The median survival of the elderly patients was 6.5 (95% CI 2.0--7.9) years compared with 7.7 (95% CI 7.5--7.9) years for a matched general population (*p* = 0.019).

![Survival curves of younger (\< 75 years) and elderly (⩾ 75 years) patients.\
OHCA, out-of-hospital cardiac arrest.](10.1177_1753944718792420-fig2){#fig2-1753944718792420}

![Survival curve elderly *versus* matched control population with 95% confidence intervals.](10.1177_1753944718792420-fig3){#fig3-1753944718792420}

Neurological outcome at hospital discharge {#section15-1753944718792420}
------------------------------------------

The younger cohort had a better neurological outcome, as scored by the CPC ([Table 2](#table2-1753944718792420){ref-type="table"}). In the elderly, 73% (95% CI 57--86%) had a CPC of 1 compared with 86% (95% CI 81--90%) in the younger patients (*p* = 0.031). The incidence of poor outcome (CPC \> 2) was 7.3% (95% CI 1.5--20%) in the elderly *versus* 2.5% (95% CI 0.9--5.3%) in the younger cohort (*p* = 0.103).

Cause of death {#section16-1753944718792420}
--------------

Causes of in-hospital death did not vary substantially between age groups ([Table 2](#table2-1753944718792420){ref-type="table"}). The major cause of death was neurological damage that was deemed not compatible with survival. Other important causes of death were secondary circulatory failure and multiorgan failure ([Table 2](#table2-1753944718792420){ref-type="table"}). Of the 35 patients with a known malignancy, only one survived until end of follow up (*p* = 0.003).

Discussion {#section17-1753944718792420}
==========

From the long-term follow up of a cohort of 810 patients after OHCA, two main observations emerged. First, despite similar percentages of patients regaining spontaneous circulation, in-hospital mortality was considerably higher in elderly compared with younger patients. Second, we add to the current literature, that elderly patients who were discharged alive had a median survival of 6.5 years compared with 7.7 years in matched controls in the general population. Moreover, in these elderly patients, the neurological outcome was good in a high percentage of patients, with less than 10% with a poor neurological outcome.

Our findings confirm that elderly patients have worse outcomes than younger patients: Funada and colleagues studied 334,730 elderly (⩾ 75 years) and 23,520 very elderly (⩾ 95 years) patients,^[@bibr12-1753944718792420],[@bibr33-1753944718792420]^ and in 2017, five more studies described worse outcomes of elderly patients after 1 month: Aissaoui and colleagues (*n* = 464, ⩾ 65 years),^[@bibr34-1753944718792420]^ Andrew and colleagues (*n* = 14,678, ⩾ 65 years),^[@bibr18-1753944718792420]^ Segal and colleagues (*n* = 18,249, \> 65 years),^[@bibr14-1753944718792420]^ Sulzgruber and colleagues (*n* = 1315, ⩾ 65 years),^[@bibr15-1753944718792420]^ and Wiel and colleagues (*n* = 4347, \> 65 years).^[@bibr13-1753944718792420]^ In a study with 34,291 patients Wong and colleagues showed in 2014 that over time, the survival of the elderly at 1 year has increased.^[@bibr36-1753944718792420]^ The favorable outcome trend for functional outcome reflected by good CPC scores at 1 month was recently shown in large Japanese cohort studies.^[@bibr12-1753944718792420],[@bibr37-1753944718792420],[@bibr38-1753944718792420]^ Beesems and colleagues showed worse survival and equally favorable functional outcome in survivors compared with our study.^[@bibr39-1753944718792420]^ In 1332 patients aged ⩾ 70 years, 1-year survival in patients discharged alive was 88% and neurologic outcome, as defined by a CPC of 1 or 2, was good in 90% of patients. Winther-Jensen and colleagues showed that 70% of the very elderly patients (i.e. ⩾ 80 years) had CPC scores of 1 or 2 at 30-day follow up, which is comparable with the observed 70% elderly with a CPC score of 1 in our cohort.^[@bibr17-1753944718792420]^ Studies are unanimous on the worse short-term outcome of elderly after OHCA, but we observe that healthy aging among the survivors seems possible.

In our study, several factors were associated with both mortality and unfavorable neurological outcome. In line with observations of others, the elderly have a higher cardiovascular risk profile and more comorbidities.^[@bibr39-1753944718792420][@bibr40-1753944718792420]--[@bibr41-1753944718792420]^ We also observed a higher incidence of an initial rhythm other than VF, which is associated with a poor outcome, in the elderly patients.^[@bibr42-1753944718792420]^ Similar to Sulzgruber and colleagues, the initial rhythm and other known prognostic factors such as witnessed arrest, bystander CPR, arterial glucose, base excess and lactate levels were not associated with outcome in the elderly.^[@bibr15-1753944718792420]^ More data are needed to identify early prognostic variables, as other cohort studies did find associations between these variables and outcome.^[@bibr6-1753944718792420],[@bibr42-1753944718792420][@bibr43-1753944718792420]--[@bibr44-1753944718792420]^

Compared with other studies, the incidence of ROSC in the elderly in our population was high and almost equal to younger patients.^[@bibr47-1753944718792420],[@bibr48-1753944718792420]^ A selection bias could be present as referral to our hospital may have been considered futile in patients with very poor early prognostic variables or a nonshockable rhythm present for more than 20 minutes. Like in the study of Winther-Jensen and colleagues, CAG and PCI were employed less frequently in the elderly patients.^[@bibr17-1753944718792420]^ Our data show that in elderly patients, OHCA less frequently has an acute cardiac origin. Elderly patients less often suffer from a myocardial infarction, initial rhythm of VF and have lower cardiac biomarkers. Also, the higher incidence of previous myocardial infarction in the elderly might underlie secondary rhythm disturbances that cause OHCA. The different underlying pathology makes them less suitable for treatment such as PCI.^[@bibr6-1753944718792420],[@bibr49-1753944718792420],[@bibr50-1753944718792420]^ Another reason could be that elderly patients tend to receive a less aggressive diagnostic work up compared with younger patients.^[@bibr13-1753944718792420],[@bibr51-1753944718792420][@bibr52-1753944718792420]--[@bibr53-1753944718792420]^ MTH was employed equally in both groups in our cohort.

Treatment decisions can be particularly difficult for clinicians caring for elderly patients. CPR for older patients is a controversial issue.^[@bibr16-1753944718792420],[@bibr54-1753944718792420],55^ Initiating CPR in the elderly is a decision that is affected by sometimes conflicting opinions for what is best for the patient, and these opinions may vary from country to country. It involves not only medical, but also ethical decisions, especially when there are important associated comorbidities that directly affect the patient's prognosis.^[@bibr21-1753944718792420]^ As shown in our study, the incidence of malignancies is significantly higher in the elderly. Since long-term survival of elderly hospital survivors is reasonable with a median survival of 6.5 years, our data thus do not support the withholding of resuscitation based on age only.^[@bibr16-1753944718792420]^

Limitations {#section18-1753944718792420}
-----------

This study has several limitations. First, it was performed retrospectively on data of patients admitted to our hospital. Detailed data are lacking on the person who witnessed the arrest (EMS or bystander) and time frames of initial treatment, such as time to CPR, ACLS and ROSC for instance. Second, not all treatment was standardized; various potential sources of unidentified bias such as confounding by indication in the care of older and younger patients may be present. However, highlighting this potential bias is also an important finding in this study. Finally, these results only relate to patients presenting to the emergency unit of a single center. This limits the external validity of our findings. Some patients who were resuscitated during the study period in our region may not have been referred to our hospital, since PCI was not deemed necessary for some patients. This may explain differences in our patient population in comparison with other studies.^[@bibr10-1753944718792420],56^ As such, the outcome data we present do not pertain to the total population of patients suffering OHCA in our region.

Conclusion {#section19-1753944718792420}
==========

Despite similar rates of ROSC after OHCA in elderly and younger patients, hospital survival for elderly patients was approximately half that of younger patients. However, the majority of elderly patients who survived initial treatment had a CPC score of 1 and a lifespan that approximates that of the general population.

Supplemental Material {#section20-1753944718792420}
=====================

###### Supplements -- Supplemental material for Long-term outcome of elderly out-of-hospital cardiac arrest survivors as compared with their younger counterparts and the general population

###### 

Click here for additional data file.
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